Megan M. Wyatt, MS

Research Lab Manager, Senior Scientist
Division of Surgical Oncology, Department of Surgery, Department of Microbiology and Immunology, Winship Cancer Institute, Emory University
Atlanta, Georgia, United States

Presentation(s):

• 54: Galectin-9 is a regulator of immune interactions in the tumor microenvironment and represents a novel therapeutic target in biliary tract cancer.

  Saturday, March 23, 2024
  8:42am – 8:52am ET